Signal MIT Technology Review — 10 Breakthrough Technologies 2026: AI Drug Discovery, Backward Molecule Design
Summary
Nature reported that AI systems now possess genuine chemical expertise and assisted in synthesising 35 novel compounds. Backward molecular design tools such as PropMolFlow invert target properties into structures, improving generation speed, chemical validity and property accuracy at the same time. AI-driven iterative optimisation of EGFR inhibitors produced compounds with IC50 values of roughly 10 to 50 nM, using ChatGPT in the loop. CAS listed drug discovery, renewable energy and smart agriculture among its eight science trends for 2026. Independent search confirms MIT Technology Review published its 25th annual "10 Breakthrough Technologies" list on 12-13 January 2026, covering hyperscale AI data centers, personalized gene-editing treatments, mechanistic interpretability research on LLMs, space tourism and companion robots, but no search result specifically named a "backward molecule design" entry on that list, so this detail could not be independently corroborated beyond the original evidence.
Classification
Evidence 1
- MIT Technology Review — 10 Breakthrough Technologies 2026: AI Drug Discovery, Backward Molecule Design MIT Technology Review [Official] / Nature (d41586-026-00240-5) 2026-01-12 accessed 2026-07-28T13:54:28+00:00
Futures articles 4
- From discovery to the clinic: a full anatomy of the AI drug-discovery value chain
- The new drug value chain: who wins, who hangs on — dissecting 9 AI drug discovery companies
- A $100 million drug, built for $6 million — the prelude to pharma's structural overhaul
- The new landlord of orbit: the ISS's twilight and the dawn of 'commercial space'
Part of trends 2
Directly linked issues 0
No objects.
Relation types: supports
Public id: fm-c70ce0b6692a
